396 related articles for article (PubMed ID: 24293317)
1. Compound loss of muscleblind-like function in myotonic dystrophy.
Lee KY; Li M; Manchanda M; Batra R; Charizanis K; Mohan A; Warren SA; Chamberlain CM; Finn D; Hong H; Ashraf H; Kasahara H; Ranum LP; Swanson MS
EMBO Mol Med; 2013 Dec; 5(12):1887-900. PubMed ID: 24293317
[TBL] [Abstract][Full Text] [Related]
2. Muscleblind-Like 1 and Muscleblind-Like 3 Depletion Synergistically Enhances Myotonia by Altering Clc-1 RNA Translation.
Choi J; Personius KE; DiFranco M; Dansithong W; Yu C; Srivastava S; Dixon DM; Bhatt DB; Comai L; Vergara JL; Reddy S
EBioMedicine; 2015 Sep; 2(9):1034-47. PubMed ID: 26501102
[TBL] [Abstract][Full Text] [Related]
3. Zebrafish deficient for Muscleblind-like 2 exhibit features of myotonic dystrophy.
Machuca-Tzili LE; Buxton S; Thorpe A; Timson CM; Wigmore P; Luther PK; Brook JD
Dis Model Mech; 2011 May; 4(3):381-92. PubMed ID: 21303839
[TBL] [Abstract][Full Text] [Related]
4. Optical Mapping Approaches on Muscleblind-Like Compound Knockout Mice for Understanding Mechanistic Insights Into Ventricular Arrhythmias in Myotonic Dystrophy.
Chou CC; Chang PC; Wei YC; Lee KY
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28416514
[TBL] [Abstract][Full Text] [Related]
5. Muscleblind-like 2 (Mbnl2) -deficient mice as a model for myotonic dystrophy.
Hao M; Akrami K; Wei K; De Diego C; Che N; Ku JH; Tidball J; Graves MC; Shieh PB; Chen F
Dev Dyn; 2008 Feb; 237(2):403-10. PubMed ID: 18213585
[TBL] [Abstract][Full Text] [Related]
6. Mice lacking MBNL1 and MBNL2 exhibit sudden cardiac death and molecular signatures recapitulating myotonic dystrophy.
Lee KY; Seah C; Li C; Chen YF; Chen CY; Wu CI; Liao PC; Shyu YC; Olafson HR; McKee KK; Wang ET; Yeh CH; Wang CH
Hum Mol Genet; 2022 Sep; 31(18):3144-3160. PubMed ID: 35567413
[TBL] [Abstract][Full Text] [Related]
7. Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy.
Kanadia RN; Shin J; Yuan Y; Beattie SG; Wheeler TM; Thornton CA; Swanson MS
Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11748-53. PubMed ID: 16864772
[TBL] [Abstract][Full Text] [Related]
8. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy.
Lin X; Miller JW; Mankodi A; Kanadia RN; Yuan Y; Moxley RT; Swanson MS; Thornton CA
Hum Mol Genet; 2006 Jul; 15(13):2087-97. PubMed ID: 16717059
[TBL] [Abstract][Full Text] [Related]
9. Studying the Effect of MBNL1 and MBNL2 Loss in Skeletal Muscle Regeneration.
Yadava RS; Mandal M; Mahadevan MS
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473933
[TBL] [Abstract][Full Text] [Related]
10. Altered levels of the splicing factor muscleblind modifies cerebral cortical function in mouse models of myotonic dystrophy.
Chen G; Carter RE; Cleary JD; Reid TS; Ranum LP; Swanson MS; Ebner TJ
Neurobiol Dis; 2018 Apr; 112():35-48. PubMed ID: 29331264
[TBL] [Abstract][Full Text] [Related]
11. Muscleblind-like proteins: similarities and differences in normal and myotonic dystrophy muscle.
Holt I; Jacquemin V; Fardaei M; Sewry CA; Butler-Browne GS; Furling D; Brook JD; Morris GE
Am J Pathol; 2009 Jan; 174(1):216-27. PubMed ID: 19095965
[TBL] [Abstract][Full Text] [Related]
12. Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy.
Charizanis K; Lee KY; Batra R; Goodwin M; Zhang C; Yuan Y; Shiue L; Cline M; Scotti MM; Xia G; Kumar A; Ashizawa T; Clark HB; Kimura T; Takahashi MP; Fujimura H; Jinnai K; Yoshikawa H; Gomes-Pereira M; Gourdon G; Sakai N; Nishino S; Foster TC; Ares M; Darnell RB; Swanson MS
Neuron; 2012 Aug; 75(3):437-50. PubMed ID: 22884328
[TBL] [Abstract][Full Text] [Related]
13. A muscleblind knockout model for myotonic dystrophy.
Kanadia RN; Johnstone KA; Mankodi A; Lungu C; Thornton CA; Esson D; Timmers AM; Hauswirth WW; Swanson MS
Science; 2003 Dec; 302(5652):1978-80. PubMed ID: 14671308
[TBL] [Abstract][Full Text] [Related]
14. Mouse model of muscleblind-like 1 overexpression: skeletal muscle effects and therapeutic promise.
Chamberlain CM; Ranum LP
Hum Mol Genet; 2012 Nov; 21(21):4645-54. PubMed ID: 22846424
[TBL] [Abstract][Full Text] [Related]
15. Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy.
Thomas JD; Sznajder ŁJ; Bardhi O; Aslam FN; Anastasiadis ZP; Scotti MM; Nishino I; Nakamori M; Wang ET; Swanson MS
Genes Dev; 2017 Jun; 31(11):1122-1133. PubMed ID: 28698297
[TBL] [Abstract][Full Text] [Related]
16. (CTG)n repeat-mediated dysregulation of MBNL1 and MBNL2 expression during myogenesis in DM1 occurs already at the myoblast stage.
André LM; van Cruchten RTP; Willemse M; Wansink DG
PLoS One; 2019; 14(5):e0217317. PubMed ID: 31116797
[TBL] [Abstract][Full Text] [Related]
17. Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated disease.
Batra R; Charizanis K; Manchanda M; Mohan A; Li M; Finn DJ; Goodwin M; Zhang C; Sobczak K; Thornton CA; Swanson MS
Mol Cell; 2014 Oct; 56(2):311-322. PubMed ID: 25263597
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins.
Wang ET; Cody NA; Jog S; Biancolella M; Wang TT; Treacy DJ; Luo S; Schroth GP; Housman DE; Reddy S; Lécuyer E; Burge CB
Cell; 2012 Aug; 150(4):710-24. PubMed ID: 22901804
[TBL] [Abstract][Full Text] [Related]
19. Muscleblind-like 1 knockout mice reveal novel splicing defects in the myotonic dystrophy brain.
Suenaga K; Lee KY; Nakamori M; Tatsumi Y; Takahashi MP; Fujimura H; Jinnai K; Yoshikawa H; Du H; Ares M; Swanson MS; Kimura T
PLoS One; 2012; 7(3):e33218. PubMed ID: 22427994
[TBL] [Abstract][Full Text] [Related]
20. Age of onset of RNA toxicity influences phenotypic severity: evidence from an inducible mouse model of myotonic dystrophy (DM1).
Gladman JT; Mandal M; Srinivasan V; Mahadevan MS
PLoS One; 2013; 8(9):e72907. PubMed ID: 24039817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
